Goh Brian K P, Lee Lip-Seng, Lee Ser-Yee, Chow Pierce K H, Chan Chung-Yip, Chiow Adrian K H
Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore.
Duke-NUS Graduate Medical School, Singapore.
ANZ J Surg. 2019 Mar;89(3):201-205. doi: 10.1111/ans.14417. Epub 2018 Mar 7.
Presently, the adoption of laparoscopic hepatectomy is rapidly increasingly worldwide. However, the application of robotic hepatectomy (RH) remains limited and its role remains undefined today.
A retrospective review of 43 consecutive patients who underwent RH at two institutions in the Singapore Health Services Group.
Forty-three consecutive patients underwent 48 resections during the study period. Seven (16.3%) patients underwent major resections and seven (16.3%) underwent right posterior sectionectomies. Nineteen (44.2%) patients had tumours located in the difficult posterosuperior segments, five had multiple resections and three underwent repeat resections for recurrent tumours. RH was performed for malignant tumours in 32 (74%) patients and 16 (37.2%) had cirrhosis. Seven RH was performed with other concomitant procedures including three colectomies, three hilar lymphadenectomies and one portal vein ligation. The median operation time was 360 min (range 75-825) and the median blood loss was 300 mL (range 25-4500). There was one (2.3%) open conversion for bleeding. The median post-operative stay was 4 days (range 2-33) and there was one (2.3%) readmission. There was one (2.3%) major (>grade 2 morbidity) in a patient with concomitant anterior resection who underwent reoperation for anastomotic leak. There was no 90 day/in-hospital mortality. Comparison between RH for tumours in the anterolateral segments versus posterosuperior segments demonstrated no significant difference in perioperative outcomes.
Our initial experience demonstrated that RH is safe, feasible and associated with excellent post-operative outcomes. It can be performed successfully with low morbidity even for complex resections such as major hepatectomies, posterior sectionectomies, tumours in difficult posterosuperior segments and repeat liver resections.
目前,腹腔镜肝切除术在全球范围内的应用正在迅速增加。然而,机器人肝切除术(RH)的应用仍然有限,其作用至今仍不明确。
对新加坡医疗集团两家机构连续43例行RH的患者进行回顾性研究。
在研究期间,43例连续患者接受了48次肝切除术。7例(16.3%)患者接受了大手术切除,7例(16.3%)接受了右后叶切除术。19例(44.2%)患者的肿瘤位于困难的后上段,5例接受了多次切除,3例因复发性肿瘤接受了再次切除。32例(74%)患者因恶性肿瘤接受RH,16例(37.2%)有肝硬化。7例RH手术同时进行了其他手术,包括3例结肠切除术、3例肝门淋巴结清扫术和1例门静脉结扎术。中位手术时间为360分钟(范围75 - 825分钟),中位失血量为300毫升(范围25 - 4500毫升)。有1例(2.3%)因出血转为开腹手术。中位术后住院时间为- 4天(范围2 - 33天),有1例(2.3%)再次入院。1例同时行前切除术的患者因吻合口漏再次手术,发生1例(2.3%)严重(>2级并发症)并发症。无90天/住院死亡率。前外侧段肿瘤与后上段肿瘤的RH手术围手术期结果比较无显著差异。
我们的初步经验表明,RH是安全、可行的,且术后效果良好。即使对于复杂的肝切除术(如大肝切除术、后叶切除术、困难的后上段肿瘤切除术和再次肝切除术),也能以低发病率成功进行。